Latest News and Press Releases
Want to stay updated on the latest news?
-
WESTMINSTER, Colo., April 01, 2026 (GLOBE NEWSWIRE) -- Highridge Medical, a leading privately held global spine company with a portfolio supported by extensive clinical evidence, announced that,...
-
MISSISSAUGA, Ontario, April 01, 2026 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, TSX Venture: RX) is pleased to announce that FeraMAX® has been named the #1 recommended over-the-counter (OTC)...
-
TOKYO, April 01, 2026 (GLOBE NEWSWIRE) -- MIMARU, Japan’s leading apartment-style hotel brand for families and groups, operated by Cosmos Hotel Management Co., Ltd., has announced its expanding...
-
PDUFA target action date of November 14, 2026 Potential first FDA-approved treatment option for the acute treatment of agitation associated with bipolar disorders or schizophrenia in the at-home...
-
Dublin, April 01, 2026 (GLOBE NEWSWIRE) -- The "Advanced Renal Cell Carcinoma Treatment Market Report 2026" has been added to ResearchAndMarkets.com's offering. The report outlines...
-
ALK (ALKB:DC / Nasdaq Copenhagen: ALK B): According to the company’s remuneration policy adopted at the company's Annual General Meeting on 16 March 2026 and in line with the company’s usual practice,...
-
Investors who lost money in SLNO after its stock plunged due to allegedly misleading financial statements are urged to contact Hagens Berman.
-
NanoDefense Pro 2026: Nano-ingredient label disclosures, colloidal silver context, CELLg8 claims, pricing, and refund terms reviewed for consumers.
-
SALT LAKE CITY, March 31, 2026 (GLOBE NEWSWIRE) -- INTERMOUNTAIN NEWS RELEASE Approximately 1 in 15 children in Utah will experience the death of a parent or sibling before the age of 18....
-
NEW YORK, March 31, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Soleno Therapeutics, Inc. (“Soleno” or the “Company”) (NASDAQ: SLNO). Such...